A Double-blinded 6-week Prospective Study to Evaluate the Remission Rate According to Dose of Escitalopram (Lexapro) in Patients With Major Depressive Disorder: a Preliminary Study.
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms LEADERS
- 05 Sep 2018 Status changed from recruiting to completed.
- 07 Dec 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 07 Dec 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Jun 2016, as reported by ClinicalTrials.gov.